Alvogen

Natco and Alvogen partnered on the first Abbreviated New Drug Application (ANDA) containing a paragraph IV certification filed with the US Food and Drug Administration (FDA) for generic versions of Tamiflu oral capsules (oseltamivir phosphate) of 30 mg, 45 mg and 75 mg strengths.

Natco up 4% on settlement with US cos for antiviral drug

Natco and Alvogen have partnered on the first abbreviated new drug application (ANDA) containing a paragraph IV certification filed with the US Food and Drug Administration (FDA) for generic versions of Tamiflu oral capsules (oseltamivir phosphate), 30 mg, 45 mg and 75 mg.

Natco Pharma surges over 50% in 6 days, Antique says buy

Natco Pharma has been buzzing for the sixth consecutive day on Friday following approvals to launch hepatitis drug in India & Nepal as well as US court's decision on Tamiflu drug. The stock rallied 10 percent intraday to hit a new high of Rs 2,264.

Natco Pharma soars 6% post US court order on Tamiflu patent

The US Supreme Court has declined a review of a federal circuit court ruling that favoured Natco Pharma in a patent infringement litigation over swine flu treatment drug Tamiflu.

Strides Arcolab hits new high on US nod for antibiotic

Pharma company Strides Arcolab has received approval from US Food and Drugs Administration for Vancomycin Hydrochloride capsules of 125 mg and 250 mg strengths.

At-risk launch likely for Tamiflu generic: Natco Pharma

In an interview with CNBC-TV18, Bhaskar Narayana, Finance Director & CFO, Natco Pharma gave his perspective on the tie-up with Alvogen and the first-to-file opportunity for Tamiflu.